Open AccessTransient disappearance of CD19 + /CD5 + B‐lymphocyte clone in peripheral blood in a patient with CLL during SARS‐CoV‐2‐related mild disease
Author(s) -
Barnabei Remo,
Di Michele Giulio,
Cellini Antonio,
Amicosante Gianfranco,
Perilli Mariagrazia,
Bellio Pierangelo,
Piccirilli Alessandra,
Celenza Giuseppe
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4238
Subject(s) - medicine , clone (java method) , cd19 , cd5 , lymphocyte , peripheral blood , immunology , disease , peripheral , virology , flow cytometry , dna , biology , genetics
Although lymphopenia is currently considered a good predictor for the prognosis of COVID‐19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.